Skip to main content
Premium Trial:

Request an Annual Quote

Marc Jones

Atlas Genetics has announced today that it has appointed Marc Jones as COO and CFO. Jones will lead Atlas' finance and operations functions, as well as new channel development. Prior to Atlas, Jones served as COO and CFO of Good Start Genetics, where he raised successive rounds of capital. Jones also served as CFO of T2 Biosystems, where he oversaw the company's public offering and helped drive commercialization of the company's first FDA IVD product. Previously, Jones was CFO at Crashlytics, Ivenix, and Chil Semiconductor.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.